Abstract
The concentrations of selected metabolites in the posterior temporoparietal cortex of 13 Alzheimer's diseased (AD) and four nondemented postmortem brains (of individuals between the ages of 63 and 95) were determined using high-resolution 1H nuclear magnetic resonance (NMR) spectroscopy. The estimates for glutamate and inositol for AD brains did not show any statistically significant difference (P>0.05) from those for the nondemented brains. The putative neuronal marker N-acetyl aspartate (NAA), creatine, and GABA were decreased in AD brains compared with the nondemented brains. The estimates for creatine, glutamate, and GABA showed significant linear correlations with those of NAA. Creatine, glutamate, GABA, and NAA appeared to be negatively correlated with the neurofibrillary tangles. Our results support a neuronal loss in the posterior temporoparietal cortices of AD brains.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ball MJ, Fisman M, Hachinski V, Blume W, Fox A, Kral VA, Kirshen AJ, Fox H, Merskey H (1984) A new definition of Alzheimer's disease: a hippocampal dementia. Lancet 1:14–16
Bilken DL, Oldendorf WH (1989) N-acetyl-l-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 13:23–31
Bovee WMMJ (1991) Quantification of glutamate, glutamine and other metabolites in in vivo proton NMR spectroscopy. NMR Biomed 4:81–84
Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459–496
Braak M, Braak E, Grundke-Iqbal I, Iqbal K (1986) Occurrence of neuropil threads in the senile brain and in Alzheimer's disease: a third location of the paired helical filaments outside neurofibrillary tangles and neuritic plaques. Neurosci Lett 65:351–355
Frahm J, Michaelis T, Merboldt KD, Hanicke W, Gyngell MI, Bruhn H (1991) On the N-acetyl methyl resonance in localized 1H NMR spectra of human brain in vivo. NMR Biomed 4:201–204 (and references 3–5, 11, 12, 16 cited therein)
Halper J, Scheithauer B, Okazaki H, Laws ER Jr (1986) A report of six cases with special reference to neurofibrillary tangles. JNeuropathol Exp Neurol 45:426–446
Holowenko D, Peeling J, Sutherland G (1992) 1H NMR properties of N-acetyl aspartyl glutamate in extracts of nervous tissues of rat. NMR Biomed 5:44–49
Klunk WE, Panchalingam K, Moossy J, McClure RJ, Pettegrew JW (1992) N-acetyl-l-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary nuclear magnetic resonance study. Neurology 42:81–93
Koller KJ, Zaczek R, Coyle JT (1984) N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 43:1136–1142
Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein, τ(tau) is a major antigenergic component of the paired helical filaments in Alzheimer's disease. Proc Natl Acad Sci USA 83:4044–4048
Kowall NW, Kosik KS (1987) Axonal disruption and aberrant localization of the tau protein characterize the neuropil pathology of Alzheimer's disease. Ann Neurol 22:639–643
Lowe SL, Bowen DM, Francis PT, Neary D (1990) Antemortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38:571–577
Miller BL, Moats RA, Shonk T, Ernst Th, Woolley S, Ross BD (1993) Alzheimer's disease: depiction of increased myo-inositol with proton MR spectroscopy. Radiology 187:433–437
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The Consortium to Establish Registry for Alzheimer's Disease (CERAD), part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 2:1457–1459
Petroff OAC, Ogino T, Alger JR (1988) High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J Neurochem 51:163–177
Petroff OAC, Spencer DD, Alger JR, Pritchard JW (1989) High resolution proton magnetic resonance spectroscopy of human cerebrum obtained during surgery during epilepsy. Neurology 39:1197–1202
Rothman DL, Hanstock CC, Petroff OAC, Novotny EJ, Prichard JW, Shulman RG (1992) Localized 1H NMR spectra of glutamate in the human brain. Magn Reson Med 25:95–106
Stokes EC, Hawthorne JN (1983) Free and total lipid myo-inositol concentrations decrease with age in human brain. Biochim Biophys Acta 753:136–138
Stokes EC, Hawthorne JN (1987) Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer diseased brains. J Neurochem 48:1018–1021
Summers WK, Majouski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315:1241–1245
Tapia R, Sitges M (1982) Effect of 4-aminopyridines on transmitter release in synaptosomes. Brain Res 250:291–299
Tomlinson BE (1992) Aging and dementias. In: Adams JH, Duchen LW (eds) Greenfield's Neuropathology, 5th edn. Oxford University Press, New York, pp 1284–1410
Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981–989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mohanakrishnan, P., Fowler, A.H., Vonsattel, J.P. et al. An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains. Exp Brain Res 102, 503–510 (1995). https://doi.org/10.1007/BF00230654
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00230654